$XFOR 8-K SEC Filings

Filed On	Filing
08 Oct 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more - Strengthens Financial Flexibility with Access to Funding for Corporate and Commercial Activities -
09 Sep 2026	8-K: Other Events Corporate Presentation September 2026 Nasdaq: XFOR EXHIBIT 99.1
08 Sep 2026	8-K: Other Events - FDA Agrees to Reduced Sample Size for the Global 4WARD Phase 3 Chronic Neutropenia Trial -
01 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
12 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
05 Nov 2025	8-K: Results of Operations and Financial Condition
27 Oct 2025	8-K: Entry into a Material Definitive Agreement
17 Sep 2025	8-K: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation +1 more
25 Aug 2025	8-K: Departure/Election of Directors or Officers; Compensation
13 Aug 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
12 Aug 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
23 Jun 2025	8-K: Entry into a Material Definitive Agreement
11 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
01 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
24 Apr 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events
18 Apr 2025	8-K: Submission of Matters to a Vote of Security Holders
25 Mar 2025	8-K: Results of Operations and Financial Condition
03 Mar 2025	8-K: Other Events
06 Feb 2025	8-K: Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure
13 Jan 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Comments